產(chǎn)品名稱：兔抗TAZ多克隆抗體

Background:

This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.

Applications:

WB

Name of antibody:

TAZ

Immunogen:

Synthesized peptide derived from Internal of human TAZ.

Full name:

tafazzin

Synonyms：

EFE; BTHS; EFE2; G4.5; Taz1; CMD3A; LVNCX

SwissProt:

Q16635

WB Predicted band size:

33 kDa

WB Positive control:

HepG2 cells lysate

WB Recommended dilution:

500-3000